Five stocks are walking into Thursday’s session with five very different catalysts, and at least two of them don’t tell the same story on the surface as they do underneath. UltraTech Cement is absorbing a ₹1,908-crore promoter block deal at a discount.
Apollo Hospitals beat profit estimates and still closed lower. Ircon International’s profit is up 8.6% on one number and down 43.9% on another, depending on which one investors are reading. Tata Motors Passenger Vehicles reports results later today after volumes already jumped 46%, and Axis Bank quietly wrapped up a $600-million dollar-bond raise. The real question for traders: which of these catalysts is already priced in, and which one still has room to move the stock today?
Need to Know
- UltraTech Cement faces a ₹1,908-crore block deal today as promoter entity Pilani Investment and Industries Corporation sells a 0.6% stake at a 3% discount to Wednesday’s ₹11,836 close.
- Apollo Hospitals’ consolidated net profit rose 38.4% YoY to ₹610 crore — yet the stock still closed lower, a clear expectation-gap session.
- Ircon International’s standalone profit rose 8.6% YoY, but consolidated profit, the more widely tracked figure, fell 43.9% YoY on joint-venture losses.
- Tata Motors Passenger Vehicles reports Q1 FY27 results later today after PV wholesales rose 46% YoY to 182,574 units; this is a separate listed entity from Tata Motors Ltd (CV business), which posted an 83% YoY profit jump on August 12.
- Axis Bank completed a $600-million overseas bond series and a routine ESOP-linked share allotment.
- Nifty 50 closed 0.15% lower at 24,435.95 on Wednesday as Brent crude neared $90/barrel on Middle East tensions.
Market Setup for August 13
The Nifty 50 closed Wednesday’s session at 24,435.95, down 35.75 points, while the Sensex fell 187.90 points to 77,966.35. The index formed a lower-high, lower-low pattern through the first half before finding support above 24,250 and paring losses into the close.
Bank Nifty bucked the trend, adding 439.60 points to end at 57,885.85 as banking and metal counters outperformed.
Elevated crude oil prices remained the dominant overhang, with Brent trading near $89–90 a barrel amid fresh Middle East tensions and uncertainty around Strait of Hormuz shipping. IT and FMCG stocks stayed under pressure through the session.
Check Live: NIFTY50, SENSEX, BANK NIFTY, GIFT NIFTY | NIFTYTRADER
UltraTech Cement: A ₹1,908-Crore Overhang Before the Open
Pilani Investment and Industries Corporation is selling roughly 17 lakh shares of UltraTech Cement — about 0.6% of outstanding equity, through a vendor sale on the exchanges’ screen-based platform, with the trade expected to complete today.
The floor price is set at ₹11,481 per share, a 3% discount to UltraTech’s last close of ₹11,836. The deal, worth roughly ₹1,908–1,909 crore, is entirely secondary, carries a 60-day lock-up, and is aimed at institutional investors only, with settlement expected August 14.
Separately, UltraTech has informed exchanges of a proposed 26% stake acquisition in Solaris Horizon Energy as part of its green-energy push. This detail currently traces to a single source and is worth an independent confirmation pass before it’s treated as confirmed.
The backdrop: UltraTech’s Q1 FY27 results, declared July 20, showed consolidated net profit rising 17.2% YoY to ₹2,604 crore on a 16% rise in net sales to ₹24,465 crore, per the company’s own investor filing. Domestic grey cement volumes grew 13.1% YoY, and the company has reiterated plans to enter the wires-and-cables segment in Q3 FY27. The trading question today isn’t the fundamentals, it’s how the stock absorbs a large discounted block hitting the market at the open.
Apollo Hospitals: A Profit Beat the Market Didn’t Reward
Apollo Hospitals Enterprise’s exchange filing reported consolidated net profit of ₹610 crore for Q1 FY27, up 38.4% YoY from ₹441 crore. A separate market report puts the comparable beat-adjusted figure at ₹581 crore, up 34% YoY against a Bloomberg poll estimate of ₹555.4 crore, a gap that reflects differing reporting adjustments rather than a genuine dispute over performance.
Revenue and EBITDA prints are consistent across sources: revenue rose 20.6–21% YoY to approximately ₹7,043–7,044 crore, and EBITDA rose 28.2% YoY to ₹1,092 crore, taking margin to 15.5% from 14.6% a year earlier. Healthcare services revenue grew 22% YoY to ₹3,567 crore.
Despite the beat, the stock closed lower on results day, the market’s reaction wasn’t aligned with the headline growth, which makes this one of the clearest expectation-gap stories of the day.
Alongside earnings, Apollo flagged a proposed slump-sale of Apollo HealthCo’s FMCG and wellness distribution business to Apollo Consumer Products, with a targeted HealthCo demerger and separate listing by Q4 FY27, a structural story that may matter more to the stock over the next two quarters than this print did.
Ircon International: One Company, Two Very Different Profit Stories
Ircon International’s board approved Q1 FY27 results on August 12, and the standalone-versus-consolidated gap is the real headline here. On a standalone basis, profit after tax rose 8.6% YoY to ₹163.52 crore on operating revenue of ₹1,800.27 crore, up 8.2% YoY.
But on a consolidated basis, the number typically used as the market’s headline print, net profit fell 43.9% YoY to ₹92.03 crore from ₹164.10 crore, even as consolidated revenue from operations rose 9.5% YoY to ₹1,955.83 crore.
Consolidated EBITDA declined to ₹278.7 crore from ₹323.9 crore, and PBT fell to ₹126.8 crore from ₹211.5 crore. The company has attributed the drag to losses in joint ventures and subsidiaries under construction, along with higher finance costs.
That divergence matters because several wire reports have cited only the standalone rise, understating what happened at the consolidated level. Ircon’s order book stood at ₹23,366 crore as of June 30, dominated by railway projects (77%, ₹17,989 crore), followed by highways (16%) and other segments (7%); 91% of the book is domestic. The company also appointed Vimal Kishor Nagar and P.V. Sreekanth as Executive Directors, effective August 7.
Tata Motors Passenger Vehicles: The Forward-Looking Wildcard
Tata Motors Passenger Vehicles Ltd (TMPV), the entity housing the company’s PV and EV business since its 2025 demerger, is due to announce Q1 FY27 results later today, with no fixed disclosure time set.
Ahead of the print, provisional Q1 FY27 sales data showed total passenger vehicle wholesales of 182,574 units, up 46% YoY from 124,809 units, with EV volumes also reported to have expanded sharply.
The volume story is already known; what isn’t is the margin and profitability commentary that comes out of today’s board meeting, the real swing factor for the stock.
Important distinction: TMPV is a separate listed company from Tata Motors Ltd, which now houses the commercial vehicle business and reported its own Q1 FY27 numbers a day earlier, on August 12.
Tata Motors Ltd’s consolidated net profit rose 83% YoY to approximately ₹2,556–2,560 crore against ₹1,397 crore a year earlier, helped by a mark-to-market gain on its Tata Capital holding along with strong CV volumes. Consolidated revenue rose 19.3% YoY to ₹20,667 crore, and standalone CV wholesales grew 26% YoY to 108,700 units.
Also Read: Tata Motors CV Q1: 26% Volume Surge, ₹19,329 Cr Core Revenue — Margin Squeeze
Axis Bank: A Routine Capital-Markets Update
Axis Bank completed allotment of $300 million in 5.348% senior notes, priced at 99.544% of face value, consolidating with an earlier $300-million tranche from June 30 to take the combined series to $600 million under the bank’s $5-billion Global Medium Term Note programme.
The notes mature June 30, 2031 and will list on the India International Exchange (IFSC) and NSE IFSC. The bank separately allotted 11,32,709 equity shares on August 11 following ESOP/RSU exercises, marginally raising paid-up capital.
Both disclosures are routine capital-markets and compliance items rather than results- or deal-driven catalysts, worth noting for the record, but unlikely to be the reason Axis Bank moves today.
Also in Focus: More Q1 FY27 Earnings and Deals
| Company | Q1 FY27 Headline Number | Context |
|---|---|---|
| Lenskart Solutions | Consolidated PAT +269.24% YoY to ₹221.84 cr; revenue +43.26% to ₹2,714.18 cr | PAT margin expanded to 8.4% from 4% a year earlier |
| Astral Ltd | Consolidated PAT +51.8% YoY to ₹120.2 cr; revenue ₹1,578 cr (+15.9%) | Aided by first-time consolidation of the DSS acquisition |
| GMR Airports | Consolidated PAT reported at ₹91 cr or ₹148 cr for the same quarter (vs. a ₹211.6-cr loss YoY); revenue +23.7% to ₹3,964 cr | Range reflects a revised useful-life policy on airport buildings (30 to 50 years), cutting depreciation by ~₹151 cr |
| Gujarat Pipavav Port | Consolidated PAT +41–42% YoY to ~₹147 cr; revenue +32.6% to ₹331.8 cr | Steady volume-led growth |
| Petronet LNG | Profit (total comprehensive income) +35.1% YoY to ₹1,137.15 cr; revenue -53.2% to ~₹5,558 cr | Revenue drop reflects a high year-ago base, not a demand issue |
| IRCTC | Revenue +18% YoY to ₹1,369.53 cr; net profit roughly flat at ₹329.86 cr | Steady-state quarter |
| Jio Financial Services | Bank of America to acquire 26.5% (up to 49.9%) of Jio Credit; investment up to ₹18,268 cr (~$1.9 bn) | Jio Credit AUM at ₹30,667 cr as of June 30 |
| Vascon Engineers | Received ₹126.39-cr LoI from Wardha-Nagpur PWD for a 300-bed hospital | Completion timeline: 24 months |
NiftyTrader Desk View
| Stock | Key Technical Trigger | Trader View |
|---|---|---|
| UltraTech Cement | ₹1,908-cr block deal at 3% discount to ₹11,836 close | Watch how the counter absorbs the discounted block supply through the session |
| Apollo Hospitals | Profit and EBITDA beat estimates, but stock closed lower | An expectation-gap stock; HealthCo demerger timeline and margin trajectory remain in focus |
| Ircon International | Standalone PAT +8.6%, consolidated PAT -43.9% on JV losses | The standalone-consolidated gap could keep the stock choppy until clarity emerges |
| Tata Motors PV | Q1 FY27 results awaited; PV volumes already up 46% YoY | Post-results volatility likely once margin commentary is out; volume beat may already be priced in |
| Axis Bank | $600-mn bond series completed; ESOP-linked share allotment | Price action likely to track the broader Bank Nifty trend |
Bottom Line
Today’s session splits cleanly into what’s already known and what isn’t. UltraTech’s block deal and Axis Bank’s bond allotment are supply-and-capital-markets events with limited surprise left in them.
Apollo and Ircon are the differentiators, one a beat the market refused to reward, the other a profit number that reads completely differently depending on which balance sheet you trust.
Tata Motors PV is the one still to be decided: strong volumes are already banked, and profitability is the only open question left before the board meeting closes it out.
For traders, the Ircon standalone-versus-consolidated gap and Apollo’s post-results price action are the two threads most likely to still be moving by the closing bell.
Read Next: HAL Q1 FY27 Results: ₹1,590 Cr Profit Is Only Half the Story—Stock Hits 52-Week High
Frequently Asked Questions
Why did Apollo Hospitals’ stock fall despite a profit beat?
Consolidated net profit rose 38.4% YoY to ₹610 crore, beating a Bloomberg poll estimate of ₹555.4 crore, but the stock still closed lower, a sign the market wanted stronger margin expansion or was pricing in the pending HealthCo demerger rather than the headline profit number.
What’s the difference between Ircon’s standalone and consolidated Q1 FY27 profit?
Standalone PAT rose 8.6% YoY to ₹163.52 crore, but consolidated PAT, which includes joint ventures and subsidiaries — fell 43.9% YoY to ₹92.03 crore, dragged down by JV losses and higher finance costs.
Is Tata Motors Passenger Vehicles the same company as Tata Motors Ltd?
No. Since the 2025 demerger, Tata Motors Ltd houses the commercial vehicle business, which reported an 83% YoY profit jump on August 12, while Tata Motors Passenger Vehicles Ltd is a separately listed entity covering PV and EV, with Q1 FY27 results due today.
What is the UltraTech Cement block deal about?
Promoter entity Pilani Investment and Industries Corporation is selling about 0.6% of UltraTech Cement, roughly 17 lakh shares worth ₹1,908–1,909 crore, at a 3% discount to Wednesday’s close, with settlement expected August 14.
Why do GMR Airports’ Q1 FY27 profit figures differ between reports?
The gap between the ₹91-crore and ₹148-crore figures stems from a revised useful-life policy on airport buildings (extended from 30 to 50 years), which cut depreciation by about ₹151 crore for the quarter; different reports have applied this adjustment differently.
Track FII and DII cash-market activity on the NiftyTrader FII-DII Tracker for real-time institutional flow data ahead of today’s session.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult a SEBI-registered financial advisor before making any investment decisions.
